Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (6) , 717-728
- https://doi.org/10.1016/0192-0561(88)90025-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Cyclosporin a in rheumatoid arthritis: preliminary clinical results of an open trialArthritis & Rheumatism, 1987
- Weekly Pulse Methotrexate in Rheumatoid ArthritisAnnals of Internal Medicine, 1985
- An update on human interleukin-1: From molecular biology to clinical relevanceJournal of Clinical Immunology, 1985
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Interleukin-1Clinical Infectious Diseases, 1984
- Models of arthritis and the search for anti-arthritic drugsPharmacology & Therapeutics, 1983
- Inhibition of T‐Cell Activity by Cyclosporin AScandinavian Journal of Immunology, 1982
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responsesInternational Journal of Immunopharmacology, 1981
- Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.BMJ, 1978